Internal Medicine

Movement disorders

Questions discussed in this category

What medications do you prioritize or avoid in Parkinson’s Disease-related psychosis and behavioral disturbance?

2 Answers available

What is the best treatment for treatment resistant restless leg syndrome?

1 Answer available

How do you treat extrapyramidal symptoms secondary to anti-psychotic use in patients who have not benefited from cogentin or benadryl?

1 Answer available

How do you approach the psychiatric symptom management of Huntington’s Disease?

1 Answer available

What are the recommendations for considering deep brain stimulation in a patient with tremors and dementia or mild cognitive impairment?

Does the approach differ if the tremor stems from essential tremor or Parkinson's disease?

1 Answer available

Is it possible to develop worsening motor features of Parkinson's disease (PD) when using clozapine (for treatment of PD psychosis) above a certain dose?

If so, what is the recommended maximum dose of clozapine for PD patients?

1 Answer available

In patients chronically treated for Wilson's disease with trientine hydrochloride (Syprine®), would you expect development of neurologic symptoms?

1 Answer available

How do you approach the workup and management of patients with suspected functional neurologic disorders?

What testing do you typically proceed with?

1 Answer available

Papers discussed in this category

Gut, 2006 May 18

Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.

Mov Disord Clin Pract, 2022 Oct 23

Clozapine Is Severely Underused in Parkinson's Disease Patients.

Frontiers in human neuroscience, 2022 May 13

Cognitive Impact of Deep Brain Stimulation in Parkinson's Disease Patients: A Systematic Review.

Frontiers in human neuroscience, 2024 Feb 02

Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: a systematic review.

The Lancet. Neurology, 2013-07

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Journal of neurology, neurosurgery, and psychiatry, 2014 May 14

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).

Journal of neurology, neurosurgery, and psychiatry, 2010 Apr 14

Factor analysis of behavioural symptoms in Huntington's disease.

The American journal of psychiatry, 2005 Apr

Critical periods of suicide risk in Huntington's disease.

Related Topics in Internal Medicine